Condition: Ulcerative Colitis · Sponsor: Pfizer
The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely active ulcerative colitis in adolescents (≥ 12 years up to \< 18 years of age). Participants who will complete the total 52-week treatment period will have the opportunity to continue in a Long-Term Extension (LTE) Period of up to 4 years (5 years after study enrollment).
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| Arkansas Children's (IP Address) | Little Rock, Arkansas, United States | Not Yet Recruiting |
| Arkansas Children's | Little Rock, Arkansas, United States | Not Yet Recruiting |
| Valley View Wellness Medical Center | Garden Grove, California, United States | Recruiting |
| Loma Linda Children's Hospital | Loma Linda, California, United States | Not Yet Recruiting |
| Loma Linda University Clinical Trial Center | Loma Linda, California, United States | Not Yet Recruiting |
| Loma Linda University Eye Institute | Loma Linda, California, United States | Not Yet Recruiting |
| Loma Linda University Medical Center | Loma Linda, California, United States | Not Yet Recruiting |
| Loma Linda University Pediatric Clinics | Loma Linda, California, United States | Not Yet Recruiting |
| Loma Linda University Children's Hospital Pediatric Specialty Clinics | San Bernardino, California, United States | Not Yet Recruiting |
| University of California San Francisco, | San Francisco, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| University of California,San Francisco Pediatric ClinicalResearch Center (PCRC) | San Francisco, California, United States | Recruiting |
+ 33 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05287126